Penningtons Manches has settled a claim against a dermatologist for a delayed diagnosis of the genetic condition Muir-Torre syndrome (MTS) which subsequently led to a delayed diagnosis of bowel cancer.
The client was diagnosed with bowel cancer in December 2011. He underwent a right hemi-colectomy for a poorly differentiated cancer that had extended beyond the muscle wall of the bowel but fortunately had not spread to his lymph nodes, liver or lungs. The delayed diagnosis had an impact on his employment as a dental surgeon due to ongoing functional bowel problems.
Following his bowel cancer diagnosis, the client underwent investigations which discovered that he had MTS, a genetic condition that predisposes a person to certain types of cancer, including bowel and colon cancer.
Our client learned that, when he underwent removal of a skin lesion by a private dermatologist in 2004, the pathologist who reviewed the biopsy had advised the dermatologist to investigate the possibility that the client might have MTS. The dermatologist ignored that recommendation. The dermatologist’s failure to inform our client or his GP about this, and to instigate investigations by referral to an appropriate specialist, resulted in our client suffering a delayed diagnosis of MTS for seven years.
The clinical negligence team obtained expert evidence which confirmed that the dermatologist was negligent for failing to act on the pathologist’s recommendation. Expert evidence also confirmed that, if our client had been diagnosed with MTS in 2004, he would have undergone regular screening investigations, including an annual colonoscopy. On the balance of probabilities, a colonoscopy would have identified and removed the pre-cancerous polyp in his colon before it developed into cancer. He would have avoided the bowel cancer and the need for cancer treatment. No further treatment or intervention would have been required.
The claim was settled after service of court proceedings and following negotiations between the parties and the acceptance of a Part 36 offer from the defendant.